Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to Comment on: "Prognostic Relevance of Primary Tumor Sidedness in Early-Stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A)".
Ouchi A, Tsukamoto S, Takashima A, Shimada Y, Hamaguchi T, Inomata M, Takii Y, Sadachi R, Kanemitsu Y. Ouchi A, et al. Among authors: sadachi r. Ann Surg Open. 2024 Oct 16;5(4):e505. doi: 10.1097/AS9.0000000000000505. eCollection 2024 Dec. Ann Surg Open. 2024. PMID: 39711655 Free PMC article. No abstract available.
Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study.
Tokura M, Ando MM, Kojima Y, Kitadai R, Yazaki S, Atutubo CMN, Li RK, Perez MZ, Gorospe AE, Madrid MA, Ordinario MVC, Imasa MSB, Sudo K, Shimoi T, Suto A, Kohsaka S, Machida R, Sadachi R, Yoshida M, Yatabe Y, Hata T, Nakamura K, Yonemori K, Shiino S. Tokura M, et al. Among authors: sadachi r. Breast Cancer (Auckl). 2024 Oct 27;18:11782234241288671. doi: 10.1177/11782234241288671. eCollection 2024. Breast Cancer (Auckl). 2024. PMID: 39493594 Free PMC article.
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.
Ohba A, Morizane C, Kawamoto Y, Komatsu Y, Ueno M, Kobayashi S, Ikeda M, Sasaki M, Furuse J, Okano N, Hiraoka N, Yoshida H, Kuchiba A, Sadachi R, Nakamura K, Matsui N, Nakamura Y, Okamoto W, Yoshino T, Okusaka T. Ohba A, et al. Among authors: sadachi r. J Clin Oncol. 2024 Sep 20;42(27):3207-3217. doi: 10.1200/JCO.23.02010. Epub 2024 Aug 5. J Clin Oncol. 2024. PMID: 39102634 Free PMC article. Clinical Trial.
Endoscopic hand suturing using a modified through-the-scope needle holder for mucosal closure after colorectal endoscopic submucosal dissection: Prospective multicenter study (with video).
Uozumi T, Abe S, Mizuguchi Y, Sekiguchi M, Toyoshima N, Takamaru H, Yamada M, Kobayashi N, Sadachi R, Ito S, Takada K, Kishida Y, Imai K, Hotta K, Ono H, Saito Y. Uozumi T, et al. Among authors: sadachi r. Dig Endosc. 2024 Nov;36(11):1245-1252. doi: 10.1111/den.14808. Epub 2024 May 22. Dig Endosc. 2024. PMID: 38775419
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).
Okuma HS, Watanabe K, Tsuchihashi K, Machida R, Sadachi R, Hirakawa A, Ariyama H, Kanai M, Kamikura M, Anjo K, Hiramitsu A, Sekine S, Okita N, Mano H, Nishikawa H, Nakamura K, Yonemori K. Okuma HS, et al. Among authors: sadachi r. Clin Cancer Res. 2023 Dec 15;29(24):5079-5086. doi: 10.1158/1078-0432.CCR-23-1807. Clin Cancer Res. 2023. PMID: 37819940 Free PMC article. Clinical Trial.
Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A).
Ouchi A, Sadachi R, Hamaguchi T, Tsukamoto S, Shimada Y, Inomata M, Takii Y, Komori K, Shiomi A, Shiozawa M, Ohue M, Watanabe J, Ito M, Kawashima Y, Kobatake T, Souda H, Saida Y, Hashimoto T, Sano Y, Kanemitsu Y; JCOG Colorectal Cancer Study Group. Ouchi A, et al. Among authors: sadachi r. Ann Surg. 2024 Feb 1;279(2):283-289. doi: 10.1097/SLA.0000000000006076. Epub 2023 Aug 8. Ann Surg. 2024. PMID: 37551612
Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.
Okano N, Morizane C, Okusaka T, Sadachi R, Kataoka T, Kobayashi S, Ikeda M, Ozaka M, Mizutani T, Sugimori K, Todaka A, Shimizu S, Mizuno N, Yamamoto T, Sano K, Tobimatsu K, Katanuma A, Gotoh K, Yamaguchi H, Ishii H, Ohba A, Furuse J, Ueno M; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG). Okano N, et al. Among authors: sadachi r. Oncologist. 2024 Jan 5;29(1):e97-e107. doi: 10.1093/oncolo/oyad220. Oncologist. 2024. PMID: 37531645 Free PMC article.
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study.
Koyama T, Shimizu T, Kojima Y, Sudo K, Okuma HS, Shimoi T, Ichikawa H, Kohsaka S, Sadachi R, Hirakawa A, Yoshida A, Ando RM, Ueno T, Yanagaki M, Matsui N, Nakamura K, Yamamoto N, Yonemori K. Koyama T, et al. Among authors: sadachi r. Cancer Discov. 2023 Aug 4;13(8):1814-1825. doi: 10.1158/2159-8290.CD-23-0419. Cancer Discov. 2023. PMID: 37369013 Clinical Trial.
18 results